Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Pubmed ID :22326847
Publication Date : //

Cancer therapy modulates VEGF signaling and viability in adult rat cardiac microvascular endothelial cells and cardiomyocytes.


This work was motivated by the incomplete characterization of the role of vascular endothelial growth factor-A (VEGF-A) in the stressed heart in consideration of upcoming cancer treatment options challenging the natural VEGF balance in the myocardium. We tested, if the cytotoxic cancer therapy doxorubicin (Doxo) or the anti-angiogenic therapy sunitinib alters viability and VEGF signaling in primary cardiac microvascular endothelial cells (CMEC) and adult rat ventricular myocytes (ARVM). ARVM were isolated and cultured in serum-free medium. CMEC were isolated from the left ventricle and used in the second passage. Viability was measured by LDH-release and by MTT-assay, cellular respiration by high-resolution oxymetry. VEGF-A release was measured using a rat specific VEGF-A ELISA-kit. CMEC were characterized by marker proteins including CD31, von Willebrand factor, smooth muscle actin and desmin. Both Doxo and sunitinib led to a dose-dependent reduction of cell viability. Sunitinib treatment caused a significant reduction of complex I and II-dependent respiration in cardiomyocytes and the loss of mitochondrial membrane potential in CMEC. Endothelial cells up-regulated VEGF-A release after peroxide or Doxo treatment. Doxo induced HIF-1α stabilization and upregulation at clinically relevant concentrations of the cancer therapy. VEGF-A release was abrogated by the inhibition of the Erk1/2 or the MAPKp38 pathway. ARVM did not answer to Doxo-induced stress conditions by the release of VEGF-A as observed in CMEC. VEGF receptor 2 amounts were reduced by Doxo and by sunitinib in a dose-dependent manner in both CMEC and ARVM. In conclusion, these data suggest that cancer therapy with anthracyclines modulates VEGF-A release and its cellular receptors in CMEC and ARVM, and therefore alters paracrine signaling in the myocardium.

Authors : Chiusa Manuel , Hool Sara-Lynn , Truetsch Petra , Djafarzadeh Siamak , Jakob Stephan M , Seifriz Franziska , Scherer Stefan J , Suter Thomas M , Zuppinger Christian , Zbinden Stephan ,

Related products :

Catalog number Product name Quantity
HEC20 Human Cardiac Microvascular Endothelial Cells, 500,000+ Cells in T25 Flask.
HEC20 Human Cardiac Microvascular Endothelial Cells 1.0flask
cAP-0021 Human Cardiac Microvascular Endothelial Cells 1.00 flask
HEC03 Human Dermal Lymphatic Microvascular Endothelial Cells, 500,000+ Cells in T25 Flask.
HEC16 Human Large Intestine Microvascular Endothelial Cells, 500,000+ Cells in T25 Flask.
HEC13 Human Prostate Microvascular Endothelial Cells, 500,000+ Cells in T25 Flask.
HEC04 Human Glomular Microvascular Endothelial Cells, 500,000+ Cells in T25 Flask.
HEC08 Human Pancreatic Microvascular Endothelial Cells, 500,000+ Cells in T25 Flask.
HEC09 Human Retinal Microvascular Endothelial Cells, 500,000+ Cells in T25 Flask.
HEC21 Human Bladder Microvascular Endothelial Cells, 500,000+ Cells in T25 Flask.
HEC12 Human Tonsil Microvascular Endothelial Cells, 500,000+ Cells in T25 Flask.
HEC10 Human Synovial Microvascular Endothelial Cells, 500,000+ Cells in T25 Flask.
HEC02 Human Brain Microvascular Endothelial Cells, 500,000+ Cells in T25 Flask.
HEC05 Human Dermal Microvascular Endothelial Cells, 500,000+ Cells in T25 Flask.
HEC14 Human Ovarian Microvascular Endothelial Cells, 500,000+ Cells in T25 Flask.
P10308 Rat Brain Microvascular Endothelial Cells 5 x 10A5 cells/vial
31-244 TAL-1 modulates the angiogenic response of endothelial cells by stimulating cell morphogenesis and by influencing their behavior in migration. 0.05 mg
HEC04 Human Glomerular Microvascular Endothelial Cells 1.0flask
HEC05 Human Dermal Microvascular Endothelial Cells 1.0flask
HEC08 Human Pancreatic Microvascular Endothelial Cells 1.0flask
HEC09 Human Retinal Microvascular Endothelial Cells 1.0flask
HEC10 Human Synovial Microvascular Endothelial Cells 1.0flask
HEC12 Human Tonsil Microvascular Endothelial Cells 1.0flask
HEC13 Human Prostate Microvascular Endothelial Cells 1.0flask
HEC14 Human Ovarian Microvascular Endothelial Cells 1.0flask


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur | Gentaur





GENTAUR Ltd.
Unicorn House, Station Cl
Hertfordshire, Potters Bar EN6 1TL
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017
RIB 30004 00187 00010092253 10
BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG
IBAN FR76 3000 4001 8700 0100 9225 310
france@gentaur.com | Gentaur | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: +49 0241 40 08 90 86, +49 0241 95 78 94 78, +49 0241 40 08 90 86
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur | Gentaur